Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
short interest is going up
we may have a bit to go to find a bottom
this company has a ways to go to be legit
thr pharmacuetical plays though have potential for billion dollar valuations because
of the high barriers to entry
i think we may see some 5-6 cents for a bottom
australian side has some support at .088 aus but
another lackluster quarter could see that blown out
just realized they only own 51% of the derma division
not excited about that it will limit the explosion there
thanks to the hc folks explaning cannepil can
be sold unregisterd in australia but until they get through
the rest of the trials sounds like cannepil is a no go in europe
“health professional distribution“
as all these new jokers enter the market place cvsi is quietly kicking and taking names in the above portion and they are the only legit player there because of the toxicological studies. they also did clinical trials for social anxiety that few know about but the journals wont pick it up yet because they dont want to endorse hemp extracts yet. cvsi is going to help out on a massive phytocannibinoid symposium in vegas scheduled for later this year or next to help being academia on board. the anti aging folks are going to help them.
cvsi operates in the down low a lot. i like their style.
thanks good post
earnings always come out last week of march first week of april for cvsi look at past years. why are you expecting them early? yes we have not heard definetively mona is leaving but per sec agreement from decmber he will be barred from the board and being an officer for 5 years. hope the latter helps clarify things.
i guess the page 11 number is for 6 months and page 1 number is for the year but not sure why the net loss on both page 1 and page 11 are for the year.
the interim financial report has 2 different revenue numbers:
29,681 page 11
127,377 page 1
why is revenue going backwards?
120,242 for the year ending june 2017
29,681 for the 6 months ending dec 2017
something seems off here
massive natural products conference in anaheim this week
starts mid-week
they are having a summit on hemp cbd
cv sciences playing an integral part and will have at least 3 people speaking on behalf of cv sciences
if anyone lives in the area i would recommend checking it out
at least there is no toxic debt to deal with here
that is such a pain to track on the rest of the penny stocks on the otc
and it is so widespread
if they cant come up with some decent revenues this year there could be some more dilution though private placement or something
they are burning through over 1.5 million aus every quarter.
they have enough cash to get through the year thats it.
better start getting some revenues going.
some of the past cash burn could have been from building the facility in slovenia; havent dug that deep.
so maybe cash burn will slow down but i doubt it.
looks like its in reform bottom phase.
not sure how long it will take.
the cannepil play has my eye.
anyone know the current OS?
many times i let them know how dumb their article was and that it was not a criminal case but a civil case via comments. They would just repost the story a few weeks later to get more clicks with the comments gone. They are basically after clicks and do not care about posting truth. No trading would be shut down in a civil case blah.
stop reading moneymorning.com they are morons
ya they provided an update that the deal was signed off by the defendants and that the meeting by the bosses at the sec to approve the deal is scheduled for late march or early april
ya december settlement done deal still waiting on approval; late march early april will be the sec closed door meeting to approve or not approve. assuming these are routine approvals?
any word on the next ceo? need a someone with a squeaky clean background hopefully from the pharmaceutical industry.
the judge in the sec case ordered a status update by eod march 2nd unless the case is dismissed then no status update is needed.
so far crickets no updates.
tick tock tick tock.
from the single convention on narcotic drugs that the usa signed
Article 28. Control of cannabis
1. If a Party permits the cultivation of the cannabis plant for the production
of cannabis or cannabis resin, it shall apply thereto the system of controls as
provided in article 23 respecting the control of the opium poppy.
2. This Convention shall not apply to the cultivation of the cannabis
plant exclusively for industrial purposes (fibre and seed) or horticultural
purposes.
3. The Parties shall adopt such measures as may be necessary to prevent
the misuse of, and illicit traffic in, the leaves of the cannabis plant.
https://www.unodc.org/documents/commissions/CND/Int_Drug_Control_Conventions/Ebook/The_International_Drug_Control_Conventions_E.pdf
on one hand they say that once HL gets the import worked out with AUS govt then they will distribute cannepil immediately. on the other hand they say they are entering phase 2 with cannepil in europe. is the phase 2 so they can distribute in europe? they dont need full clinical trials for green light in AUS? looks like besides cultbeauty they are selling cbd to someone for vaping. the korean thing is a mess. this company needs to get there shit in order and stop making false promises on press releases. for example they say they will have gmp in slovenia by christmas but here in feb they have only interim gmp. just shut it if u cant deliver. and what the deal with damaged goods delivered for the korean contract? maybe i need to go to hotcopper if no one knows anything here.
what other revenue sources do they have coming in 2018 besides the derma line? seems like cannepil wont be getting revenues any time soon.
i correct myself they burned through 3 mil in cash just in the 2nd half of 2017 geesh thats not good. they better get that revenue going and going quick.
this thing is a mess
company needs to get to work and stop releasing press releases about deals that may or may not come to frution
also get their operations under control asap
showing major weakness
any thoughts? these guys know what they are doing?
there really coming up on this deadline
of march 2nd; starting to wonder if the
whole thing gets dismissed
there was a rumour heard
from the horses mouth of 20 mil for the year
it was not said in the context
of an exact number
so its at least 20 mil which
would be 6.5mil+.
were at 13.5m right now
couldnt find much on these guys but Aegean Ltd LLC owns 824,164 shares.
thats a pretty penny for an otc stock
i was doing some extensive research on the sector and what stocks are owned by institutions.
welp there isnt much there
the only comparables were pharmaceuticals above a buck and even stocks like axim have none
cvsi is one of the few that has this much institutional interest albeit relatively small compared to big board stocks
im leaning more towards that
to be distributed nationwide any products over the hemp definition of .3% thc will have to route through the FDA. The path through the FDA has very high barriers of entry. THC has negative side effects of encouraging the lower appetites for food and desires of the sexual nature which even out the playing field in my opinion. so it is somewhat of a mute discussion on which is better cbd products with trace thc or cbd products with higher thc levels. The bottom line is cbd products with trace thc levels will be the ones on the shelf in indiana and idaho and kentucky etc. etc. ones that have over trace amounts of thc will have to route through the fda to be distributed nationwide.
products with more than trace thc will most likely not be available nationwide over the counter or off the shelf in the next 10-20 years. the political climate and the situation with international treaties just wont allow it. those products very well may be available via a doctors prescription though.
many states like colorado and oregon and washington are regretful in some ways of legalizing higher thc products. for example colorado has had a massive influx in population and not necessarily the good kind. washington and oregon business in the market for higher thc products are being taxed to death; they cannot get any tax breaks from the federal government and the state and local taxes are killing them. there is major overproduction and many are losing fortunes with one stroke of the pen by the local city councils. nevada is really the only shining star i have seen for high thc product legalization.
looks like everyone is freaking out about a PandL loss.
I usually look at the cash flow statement to see how much cash they are burning through as a more important measurement.
They burned through 3mill last year 2017 and 2.3mill in 2016 which isnt terrible for a pharma play.
They have 8 million in the bank.
Not terribly concerned here.
That number the net cash used in operating activities obviously needs to turn around and fast but they should have revenue starting to come in this year.
thoughts?
these certifications like the they got in europe aint cheap.
the barriers to entry for a legit pharma company in this space are high.
anyone from Australia here?
this company legit?
the patient were rewarded
all .08 filled and .078 are available on the ask
panagora asset management is accumulating:
143749 -> shares accumulated Q3 2017
83343 -> shares accumulated Q4 2017
the ask went up to over 100k shares on friday.
there were plenty of shares for those that really wanted them
but only a couple hits on that.
orders on the bid arent filling at least in the USA.
the volume is a joke.
cvsi-007 at its core is an NRT for those not understanding
the brilliant thing about it is it will be the first ever FDA approved NRT with cannabidiol.
It could be revolutionary.
Getting past the FDA on safety wont be an issue.
Just got to beat the placebo.
And just got to beat the placebo by a little.
The FDA is desperate for anything that can help right now.
"...meeting last month on encouraging innovation in NRTs..."
https://www.fda.gov/NewsEvents/Speeches/ucm598073.htm?utm_source=CTPTwitter&utm_medium=social&utm_term=owned&utm_campaign=srnt-speech
revenues for Q4 projected at 6.5m to 7m.
ive had this terrible sore throat for weeks
finally i decide to rub some of the raw red balm (unactivated cbd) on the outside of my throat on my neck
bam 20 minutes later the sore throat is gone
im pretty sure it was a deep bacterial infection
wtf is this stuff